Remote Monitoring of Patients with Retinal Vein Occlusions Treated with Anti-VEGF: A Pilot Study
Open Access
- 28 March 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2330
Abstract
Purpose: To assess the feasibility and effectiveness of remote monitoring for patients with retinal vein occlusion (RVO) treated with intravitreal anti-VEGF injections. Methods: A retrospective analysis was conducted at the Eye Clinic of the University of Catania. Thirty-four eyes of 34 patients with RVO were included for a 12-month follow-up period. After a comprehensive baseline ophthalmic examination, the patients received a loading treatment consisting of three monthly intravitreal injections of anti-VEGF, followed by monthly or bimonthly remote follow-up visits at peripheral centers. Optical coherence tomography (OCT) images and clinical data were shared online with our eye clinic for remote evaluations. Data on hospital and peripheral center visits, intravitreal injections, and OCT scans were collected and analyzed. Results: The patients had an average of 5.71 ± 1.14 visits to peripheral centers and 2.1 ± 0.8 visits to our center for fluorescein angiography. The mean number of injections was 5.26 ± 1.29 and the mean improvement in best-corrected visual acuity (BCVA) was 11.47 ± 5.56 letters. Remote OCT evaluations accounted for 194 scans, there was a high agreement between two expert in-hospital examinators (Cohen’s κ = 0.927) with only 14 cases requiring hospital visits for inconclusive results. Conclusions: Remote monitoring for RVO patients significantly reduced hospital admissions for follow-up visits, reducing the clinical burden on medical staff, patients, and caregivers, while maintaining reliable patient assessments.Keywords
This publication has 42 references indexed in Scilit:
- Telemedicine in the Management of Exudative Age-Related Macular Degeneration within an Integrated health care SystemAmerican Journal of Ophthalmology, 2019
- Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein OcclusionJAMA, 2017
- Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life dataGraefe's Archive for Clinical and Experimental Ophthalmology, 2017
- Operational Components of Telemedicine Programs for Diabetic RetinopathyCurrent Diabetes Reports, 2016
- Systematic Evaluation of Optical Coherence Tomography Angiography in Retinal Vein OcclusionAmerican Journal of Ophthalmology, 2016
- Practical Management of Retinal Vein OcclusionsOphthalmology and Therapy, 2012
- The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in OphthalmologyMayo Clinic Proceedings, 2012
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009
- Cardiovascular Risk Factors for Retinal Vein Occlusion and Arteriolar EmboliThe Atherosclerosis Risk in Communities & Cardiovascular Health studiesOphthalmology, 2005